IKT - CODX SM and PERI among pre market gainers
Krystal Biotech KRYS +115% says study on VYJUVEKTM for rare skin disease met primary endpoint Petros Pharmaceuticals PTPI +62% 180 Life Sciences, Vaxart gain amid social media buzz; Petros climb over 60% NRx Pharmaceuticals NRXP +48% after Zyesami increased likelihood of survival from Critical COVID-19 Adagio Therapeutics ADGI +33% on further information on ADG20 related to Omicron Applied DNA Sciences APDN +29% on introduction plans of new Linea COVID-19 assay kit to detect Omicron Biofrontera BFRI +19% amid social media chatter Precipio (NASDAQ:PRPO) +18%. 180 Life Sciences ATNF +18% 180 Life Sciences, Vaxart gain amid social media buzz; Petros climb over 60% Inspira Technologies Oxy (NASDAQ:IINN) +15%. Inhibikase Therapeutics (NASDAQ:IKT) +18% announces publication highlighting mechanism of disease and the potential of oral c-Abl kinase inhibitor therapy for the treatment of parkinson's disease Viracta Therapeutics (NASDAQ:VIRX) +15% announces orphan drug designation granted by FDA for its all-oral combination of nanatinostat and valganciclovir (Nana-val) for the treatment of epstein barr virus-positive diffuse large B-cell lymphoma Chembio
For further details see:
CODX, SM and PERI among pre market gainers